CIK 0001267813
MRNS MARINUS PHARMACEUTICALS, INC.
Insider trading from SEC Form 4. Last filing Feb 11, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at MARINUS PHARMACEUTICALS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Scott Braunstein CHAIRMAN AND CEO buy | $6,526 5,933 shares | +2% | - | |
| 8Weak | Elan Ezickson director sell | $864 1,600 shares | -13% | - | |
| 8Weak | Marvin Johnson director sell | $869 1,610 shares | -11% | - |
Transactions
The last 51 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Scott Braunstein CHAIRMAN AND CEO | POpen-market purchase Common Stock10b5-1 | +5,933 | $1.10 | $6,526 | 304,600 | Feb 11, 2025 |
| Feb 7, 2025 | Marvin Johnson director | DDisposition to issuer Common Stock | -5,389 | $0.55 | $2,964 | 7,101 | Feb 11, 2025 |
| Feb 7, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Common Stock | -17,155 | $0.55 | $9,435 | 55,570 | Feb 11, 2025 |
| Feb 7, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Common Stock | -12,707 | $0.55 | $6,989 | 2,300 | Feb 11, 2025 |
| Feb 7, 2025 | Elan Ezickson director | DDisposition to issuer Common Stock | -8,600 | $0.55 | $4,730 | 2,300 | Feb 11, 2025 |
| Feb 7, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Common Stock | -125,064 | $0.55 | $69k | 179,536 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Common Stock | -2,300 | $0.55 | $1,265 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Common Stock | -55,570 | $0.55 | $31k | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Common Stock | -2,300 | $0.55 | $1,265 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Marvin Johnson director | DDisposition to issuer Common Stock | -7,101 | $0.55 | $3,906 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Marvin Johnson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -49,125 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Common Stock | -179,536 | $0.55 | $99k | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -98,250 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -167,825 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Marvin Johnson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,200 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -335,650 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Marvin Johnson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -32,400 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -115,418 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,200 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -360,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,375 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,375 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -77,175 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -193,050 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -115,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,250 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -290,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Elan Ezickson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Joseph Hulihan CHIEF MEDICAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,750 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -450,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,750 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -200,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,917 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,625 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Scott Braunstein CHAIRMAN AND CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | Seth H. Z. Fischer director | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,850 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Jan 21, 2025 | Elan Ezickson director | SOpen-market sale Common Stock10b5-1 | -1,600 | $0.54 | $864 | 10,900 | Jan 23, 2025 |
| Jan 21, 2025 | Marvin Johnson director | SOpen-market sale Common Stock10b5-1 | -1,610 | $0.54 | $869 | 12,490 | Jan 23, 2025 |
| Oct 10, 2024 | Timothy M Mayleben director | GGift Common Stockindirect: By Trust | -4,980 | $0.00 | $0 | 13,957 | Oct 15, 2024 |
| Oct 10, 2024 | Timothy M Mayleben director | GGift Common Stockindirect: By Trust | -1,660 | $0.00 | $0 | 12,297 | Oct 15, 2024 |
| Oct 10, 2024 | Timothy M Mayleben director | GGift Common Stockindirect: By Trust | -1,660 | $0.00 | $0 | 10,637 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Scott BraunsteinCHAIRMAN AND CEO
- Elan Ezicksondirector
- Seth H. Z. Fischerdirector
- Joseph HulihanCHIEF MEDICAL OFFICER
- Marvin Johnsondirector
- Timothy M Maylebendirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.